Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

3 Series NeoLux

K-Number: K230382 · 2023-03-24

Decision Date2023-03-24
Product CodeFTC
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

3 Series NeoLux is a medical device manufactured by Daavlin Distributing Co.. It received FDA 510(k) clearance on 2023-03-24 under approval number K230382. The device is classified under product code FTC. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the 3 Series NeoLux?

3 Series NeoLux is a medical device that received FDA 510(k) clearance on 2023-03-24. It is manufactured by Daavlin Distributing Co.. The 510(k) number is K230382.

When was 3 Series NeoLux approved by the FDA?

3 Series NeoLux received FDA 510(k) clearance on 2023-03-24, under approval number K230382.

What company makes 3 Series NeoLux?

3 Series NeoLux is manufactured by Daavlin Distributing Co..

What is the FDA product code for 3 Series NeoLux?

The FDA product code for 3 Series NeoLux is FTC.

Other Devices by Daavlin Distributing Co.

Related Devices (Code: FTC)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.